In the case of AD, for example, Qin et al. introduced compounds that act as both HDACs and acetylcholinesterase inhibitors [80,85], and Lei Wang et al. reported dual inhibitors of HDAC6 and butyrylcholinesterase (BuChE) [87]. This evidence concerns the gene HDAC6 and Alzheimer disease.